Visual Stock Resource - Weekend Scans/Stocks in Play

[starbuxsux]

La Jolla Pharm reports prelim Q4 GIAPREZA net sales were $7.2 million, up 71% from the three months ended December 31, 2018
8:01 AM ET 1/9/20 | Briefing.com

Vials of GIAPREZA shipped from distributors to hospitals (hospital demand) grew 74% for the three months ended December 31, 2019 as compared to the three months ended December 31, 2018 and 18% as compared to the three months ended September 30, 2019. For the twelve months ended December 31, 2019, preliminary GIAPREZA net sales were $23.1 million, up 129% from the twelve months ended December 31, 2018. La Jolla announced the commercial availability of GIAPREZA in the U.S. in March 2018.